Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

316 trials with published results (28%)

Research Maturity

791 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.3%

60 terminated out of 1141 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

28%

316 trials in Phase 3/4

Results Transparency

40%

316 of 791 completed with results

Key Signals

316 with results93% success60 terminated

Data Visualizations

Phase Distribution

861Total
Not Applicable (174)
Early P 1 (14)
P 1 (162)
P 2 (195)
P 3 (172)
P 4 (144)

Trial Status

Completed791
Unknown106
Recruiting81
Terminated60
Not Yet Recruiting35
Active Not Recruiting31

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 791 completed trials

Clinical Trials (1141)

Showing 20 of 20 trials
NCT07693595RecruitingPrimary

Nailfold Capillaroscopic Changes in Psoriasis

NCT04728165CompletedPrimary

Anti-Inflammatory Effects of Time-Restricted Feeding

NCT03816345Phase 1Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT07654751Phase 4Not Yet RecruitingPrimary

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

NCT07736651Not ApplicableRecruitingPrimary

Anti Inflammatory Diet With Physical Therapy on Psoriasis

NCT01778569Completed

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

NCT04864886Recruiting

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

NCT07449234TerminatedPrimary

A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

NCT05295979Phase 2CompletedPrimary

Chinese Medicine for Patients With Psoriasis

NCT07724366Phase 3Not Yet RecruitingPrimary

A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

NCT07648836Not Yet Recruiting

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

NCT07713212Phase 4Not Yet RecruitingPrimary

Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis

NCT07712731Phase 3CompletedPrimary

HPP737 in Adult Patients With Plaque Psoriasis

NCT07712705Phase 3CompletedPrimary

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

NCT07707141Phase 2CompletedPrimary

Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis

NCT07709169CompletedPrimary

Psoriasis and Its Impact on Quality of Life Among Psoriatic Patients

NCT04170244Recruiting

Skin Microbial Ecology in Atopic Dermatitis

NCT07187817RecruitingPrimary

SEquential Treatment of PSoriasis With Biologics

NCT07489885Phase 2RecruitingPrimary

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

NCT00508547Active Not RecruitingPrimary

Psoriasis Longitudinal Assessment and Registry

Scroll to load more

Research Network

Activity Timeline